Thomas Clancy, Surgical Oncologist at Brigham and Women’s Hospital, shared on LinkedIn:

“Less than one week to go until our first MGB Cancer Institute pancreatic cancer symposium.

Registration is free, space filling up.

Hear thought leaders, patients, researchers, and clinicians discuss innovation and progress in this challenging disease.”

Anna Berkenblit, Chief Scientific and Medical Officer at Pancreatic Cancer Action Network, added:

“Excited to participate in what promises to be a fantastic symposium at MGB next week!”

A day of education for health care providers, trainees, patients and familes.

Wednesday, November 18 | 8:00 am to 5:00 pm Starr Center | 185 Cambridge St, Boston, MA 02114

Objective:

Highlight advances in pancreatic cancer treatment and in the clinical and scientific Pancreatic Cancer Program at MGBCI

Schedule:

8:00 am Registration and Refreshments
8:20 am Welcome and MGBCI Pancreatic Cancer Vision
8:30 am PC Early Detection and Interception
9:25 am Keynote: Liz Jaffee, MD, Deputy Director, Sidney Kimmel Cancer Center at Johns Hopkins and Co-Director of the GI Cancer Program
10:25 am Break
10:45 am Early Detection and Interception Panel
11:15 am Beyond Treatment: Patient Perspectives on Pancreatic Cancer Care
12:30 pm Lunch: Posters, Lab Tours for Patients
1:30 pm Therapeutics Session 1: KRAS Targeting
2:15 pm Therapeutics Session 2: MGBCI Innovation Across Localized and Translational Pancreatic Cancer Research
3:00 pm Break
3:30 pm Multidisciplinary Case Conference
4:15 pm Closing Remarks
4:20 pm Reception